Jiangsu Hengrui Medicine
600276.SS
#508
Rank
C$54.93 B
Marketcap
$8.61
Share price
-0.27%
Change (1 day)
4.66%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Total assets

Total assets on the balance sheet as of June 2024 : C$8.99 B

According to Jiangsu Hengrui Medicine 's latest financial reports the company's total assets are C$8.99 B. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Jiangsu Hengrui Medicine - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2022-12-31C$8.33 B6.85%
2021-12-31C$7.79 B14.85%
2020-12-31C$6.79 B32.79%
2019-12-31C$5.11 B14.52%
2018-12-31C$4.46 B28.09%
2017-12-31C$3.48 B25.7%
2016-12-31C$2.77 B12.58%
2015-12-31C$2.46 B44.73%
2014-12-31C$1.70 B34.1%
2013-12-31C$1.26 B34.75%
2012-12-31C$0.94 B20.8%
2011-12-31C$0.77 B32.23%
2010-12-31C$0.58 B27.5%
2009-12-31C$0.46 B14.41%
2008-12-31C$0.40 B46.16%
2007-12-31C$0.27 B26.29%
2006-12-31C$0.21 B18.1%
2005-12-31C$0.18 B11.92%
2004-12-31C$0.16 B-27.96%
2003-12-31C$0.23 B0.08%
2002-12-31C$0.22 B6.72%
2001-12-31C$0.21 B